The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
fda pi zhun anoro ellipta yong yu zhi liao man xing zu sai xing fei ji bing
Pages: 125
Year: Issue:  2
Journal: World Clinical Drugs

Keyword:  Anoro ElliptaFDA慢性咳嗽混合制剂进行性加重呼吸困难葛兰素史克抗胆碱药吸入型下呼吸道感染;
Abstract: <正>2013年12月,FDA批准葛兰素史克的umeclidinium/vilanterol混合吸入粉剂(Anoro Ellipta)用于慢性阻塞性肺疾病(COPD)气流受限患者的长期维持治疗。COPD是一种能造成呼吸困难并进行性加重的严重肺部疾病。症状包括胸部紧迫感、慢性咳嗽和痰多。吸烟是导致COPD的首要原因。本品为umeclidinium和vilanterol的混合制剂。吸
Related Articles
No related articles found